MLchartDataset catalogue

CCI-779

Term · Oncology and biomedicine · MLC-T-ONC-001518

A drug used to treat advanced renal cell carcinoma (a type of kidney cancer). It is also being studied in the treatment of other types of cancer. CCI-779 blocks a protein called mTOR, which helps control cell division. Blocking this protein may help keep cancer cells from growing. CCI-779 is a type of kinase inhibitor. Also called temsirolimus and Torisel.

Table 1. Record
IdentifierMLC-T-ONC-001518
FieldOncology and biomedicine
Expansionstemsirolimus; Torisel
ReferencesNCI Dictionary of Cancer Terms
Record as JSON 
{
  "id": "MLC-T-ONC-001518",
  "term": "CCI-779",
  "field": "Oncology and biomedicine",
  "definition": "A drug used to treat advanced renal cell carcinoma (a type of kidney cancer). It is also being studied in the treatment of other types of cancer. CCI-779 blocks a protein called mTOR, which helps control cell division. Blocking this protein may help keep cancer cells from growing. CCI-779 is a type of kinase inhibitor. Also called temsirolimus and Torisel.",
  "expansions": [
    "temsirolimus",
    "Torisel"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/cci-779/"
}

Record 4,359 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.